NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000201

Registered date:13/09/2005

Therapeutic angiogenesis with acidic gelatin hydrogel microspheres incorporating fibroblast growth factor-2 for intermittent claudication

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedArteriosclerosis obliterance
Date of first enrollment2005/03/01
Target sample size10
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Intra-arterial injection of acidic gelatin hydrogel microspheres (3mg) incorporating human recombinant fibroblast growth factor-2 (trafermin, 0.1mg)

Outcome(s)

Primary OutcomePhysical findings Symptoms Maximum walking distance and time Ankle pressure index Near-infrared spectroscopy Transcutaneous oximetry Skin perfusion pressure Air plethysmography Angiography
Secondary OutcomeAdverse events Serum FGF2 concentration

Key inclusion & exclusion criteria

Age minimum40years-old
Age maximum85years-old
GenderMale and Female
Include criteria
Exclude criteria1. Hypersensitivity for gelatin hydrogel 2. Serious medical co-morbidities 3. Alcoholism or other drug dependence within 3 months 4. Malignancy within 5 years 5. Possibility of malignancy 6. Operations within 3 months 7. Severe diabetic retinopathy 8. Pregnant woman, lactating woman 9. Vascular reconstruction within 2 months 10. Other complication unsuitable for the study

Related Information

Contact

public contact
Name Hiroyuki Koyama
Address 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan Japan
Telephone 03-3815-8411
E-mail hkoyama-tky@umin.ac.jp
Affiliation The University of Tokyo Hospital Department of Vascular Regeneration
scientific contact
Name Tetsuro Miyata
Address 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan Japan
Telephone 03-3815-8411
E-mail
Affiliation The University of Tokyo Hospital Department of Surgery, Division of Vascular Surgery